Allspring Global Investments
ICVX

Allspring Global Investments’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Allspring Global Investments’s Portfolio ICVX Stock Details ICVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-18,708
Closed -$295K – 2452
2023
Q4 		$295K Buy
18,708
+5,280
+39% +$50.9K ﹤0.01% 1614
2023
Q3 		$104K Sell
13,428
-134
-1% -$1.11K ﹤0.01% 1989
2023
Q2 		$135K Sell
13,562
-2,483
-15% -$19.9K ﹤0.01% 1950
2023
Q1 		$93.1K Sell
16,045
-167
-1% -$1.44K ﹤0.01% 2081
2022
Q4 		$129K Sell
16,212
-6,330
-28% -$27.2K ﹤0.01% 1973
2022
Q3 		$71K Sell
22,542
-4,799
-18% -$30K ﹤0.01% 2219
2022
Q2 		$156K Buy
27,341
+18,100
+196% +$141K ﹤0.01% 1906
2022
Q1 		$65K Buy
9,241
+3,167
+52% +$49.8K ﹤0.01% 2816
2021
Q4 		$138K Buy
+6,074
New +$157K ﹤0.01% 2718

Allspring Global Investments's ICVX Position: Q1 2024 in Review

Allspring Global Investments sold out of Icosavax, Inc. Common Stock (ICVX) in Q1 2024, closing a stake of 18,708 shares — an estimated $295K sold.

Allspring Global Investments first reported a position in ICVX in Q4 2021 and held it in 9 quarters. The position peaked at $295K in Q4 2023. 0 funds tracked by Wall St. Rank hold ICVX as of Q1 2024.

  • Allspring Global Investments reported no remaining Icosavax, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Allspring Global Investments sold 18,708 Icosavax, Inc. Common Stock shares in Q1 2024, an estimated $295K.
  • Allspring Global Investments first reported a position in Icosavax, Inc. Common Stock in Q4 2021 and held it in 9 quarters.
  • Allspring Global Investments's Icosavax, Inc. Common Stock position peaked at $295K in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q1 2024.

Based on Allspring Global Investments's 13F filing for Q1 2024, filed 18 Apr 2024.